Ciclesonide is a corticosteroid currently approved in Europe for the treatment of inflammation that is the critical source of asthma symptoms. Data were recently presented at US conferences discussing ...

With the COVID-19 pandemic, the world has suffered hundreds of thousands of deaths and tens of millions of cases. In order to contain this outbreak, new and already approved drugs are being tested. A ...

March 22, 2005 (San Antonio) — Treatment with the new inhaled corticosteroid ciclesonide (Alvesco) is linked to improved quality of life in patients with severe asthma, according to findings presented ...

ZUG, Switzerland, April 15, 2021 (GLOBE NEWSWIRE) -- Covis Pharma Group (the “Company”), a global specialty pharmaceutical company that markets therapeutic solutions for patients with life-threatening ...

Learn everything you need to know about Ciclesonide-pronunciation, uses, dosage guidelines, indications, and when to take or avoid it. Get up-to-date information on side effects, precautions, warnings ...

Sunovion Pharmaceuticals Inc. (Sunovion) today announced the nationwide availability of ZETONNA™ (ciclesonide) Nasal Aerosol, 74 mcg once-daily, for the treatment of allergic rhinitis (AR), also known ...

Review the side-effects of Ciclesonide as documented in medical literature. The term "side effects" refers to unintended effects that can occur as a result of taking the medication. In majority of the ...

Sunovion’s Investigational Ciclesonide HFA Nasal Aerosol Effective in Treatment of Seasonal Allergic Rhinitis Symptoms Phase III data presented at AAAAI builds upon Sunovion legacy in respiratory ...

- Sepracor acquires exclusive development, marketing and commercialisation rights to the Ciclesonide franchise in the United States - Ciclesonide is the active ingredient in the ALVESCO® Inhalation ...

The Global Ciclesonide Market, by Indication (Allergic Rhinitis and Asthma), by Dosage Form (Nasal Spray and Aerosol), and by Region (North America, Asia Pacific, Latin America, Europe, Middle East, ...